HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Walter Berger Selected Research

PD 173074

12/2018Lysosomal Sequestration Impairs the Activity of the Preclinical FGFR Inhibitor PD173074.
11/2018Nanoformulations of anticancer FGFR inhibitors with improved therapeutic index.
6/2017Irinotecan Upregulates Fibroblast Growth Factor Receptor 3 Expression in Colorectal Cancer Cells, Which Mitigates Irinotecan-Induced Apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Walter Berger Research Topics

Disease

145Neoplasms (Cancer)
01/2022 - 03/2002
26Melanoma (Melanoma, Malignant)
04/2021 - 04/2002
16Glioblastoma (Glioblastoma Multiforme)
01/2022 - 03/2002
15Hepatocellular Carcinoma (Hepatoma)
10/2021 - 11/2002
15Carcinoma (Carcinomatosis)
03/2021 - 02/2006
13Glioma (Gliomas)
01/2022 - 03/2002
12Malignant Mesothelioma
01/2020 - 05/2011
11Colonic Neoplasms (Colon Cancer)
01/2022 - 01/2008
10Lung Neoplasms (Lung Cancer)
02/2021 - 02/2006
10Neoplasm Metastasis (Metastasis)
02/2021 - 04/2006
8Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 04/2015
8Brain Neoplasms (Brain Tumor)
01/2021 - 03/2002
7Hypoxia (Hypoxemia)
03/2021 - 03/2011
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2017 - 06/2005
6Mesothelioma
01/2020 - 05/2011
6Breast Neoplasms (Breast Cancer)
04/2016 - 10/2003
5Ovarian Neoplasms (Ovarian Cancer)
08/2019 - 07/2009
5Adenocarcinoma of Lung
08/2016 - 01/2013
4Disease Progression
01/2020 - 09/2009
4Osteosarcoma (Osteogenic Sarcoma)
11/2018 - 11/2015
4Liver Neoplasms (Liver Cancer)
05/2011 - 11/2006
3Hypersensitivity (Allergy)
01/2022 - 05/2011
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 04/2016
3Leukemia
03/2021 - 04/2006
3Ependymoma
01/2021 - 09/2017
3Meningioma (Meningiomas)
11/2018 - 03/2002
3Sarcoma (Soft Tissue Sarcoma)
10/2016 - 10/2012
3Infections
04/2016 - 01/2013
3Inflammation (Inflammations)
10/2009 - 11/2006

Drug/Important Bio-Agent (IBA)

30Pharmaceutical PreparationsIBA
10/2021 - 03/2002
19Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2002
15Cisplatin (Platino)FDA LinkGeneric
11/2018 - 02/2006
14Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2022 - 10/2008
14Biological ProductsIBA
04/2021 - 05/2009
13LigandsIBA
01/2022 - 01/2009
11ProdrugsIBA
10/2021 - 11/2014
10Messenger RNA (mRNA)IBA
01/2022 - 11/2002
10Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2021 - 02/2008
10ErbB Receptors (EGF Receptor)IBA
09/2017 - 10/2008
9PlatinumIBA
10/2021 - 02/2008
9Small Interfering RNA (siRNA)IBA
02/2021 - 02/2006
9Phosphotransferases (Kinase)IBA
01/2018 - 09/2009
8RutheniumIBA
01/2022 - 06/2010
8Tyrosine Kinase InhibitorsIBA
03/2021 - 10/2011
8Telomerase (Telomerase Reverse Transcriptase)IBA
01/2020 - 10/2003
8Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2019 - 07/2009
8Biomarkers (Surrogate Marker)IBA
02/2018 - 10/2009
7MetalsIBA
01/2019 - 02/2008
73-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA
01/2019 - 06/2012
7Antineoplastic Agents (Antineoplastics)IBA
01/2017 - 02/2008
6Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2022 - 01/2008
6Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2021 - 05/2007
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 10/2012
6DNA (Deoxyribonucleic Acid)IBA
08/2019 - 11/2006
6Temozolomide (Temodar)FDA LinkGeneric
05/2017 - 07/2009
5Type 4 Fibroblast Growth Factor ReceptorIBA
01/2022 - 01/2014
5ThiosemicarbazonesIBA
11/2020 - 06/2012
5multidrug resistance-associated protein 1IBA
04/2016 - 03/2002
4IntegrinsIBA
01/2022 - 05/2009
4KP 1339IBA
08/2021 - 06/2010
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020 - 06/2013
4nintedanibIBA
11/2018 - 08/2016
4Sorafenib (BAY 43-9006)FDA Link
05/2018 - 05/2009
4OsmiumIBA
02/2018 - 12/2012
4Epidermal Growth Factor (EGF)IBA
01/2018 - 07/2012
4GalliumIBA
12/2017 - 10/2009
4Member 1 Subfamily B ATP Binding Cassette TransporterIBA
04/2016 - 03/2002
4activin AIBA
03/2016 - 11/2006
4indazolium trans- (tetrachlorobis(1H- indazole)ruthenate (III))IBA
01/2014 - 10/2008
4Cytostatic AgentsIBA
09/2013 - 03/2007
3AlbuminsIBA
10/2021 - 03/2017
3ponatinibIBA
03/2021 - 11/2018
3YK 4-279IBA
10/2020 - 11/2018
3sphaeropsidin AIBA
10/2020 - 10/2015
3Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
01/2020 - 12/2015
3VemurafenibIBA
09/2019 - 03/2015
3PD 173074IBA
12/2018 - 06/2017
3Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2018 - 10/2011
3Methotrexate (Mexate)FDA LinkGeneric
12/2017 - 02/2006
3Protein Isoforms (Isoforms)IBA
01/2017 - 10/2011
3FollistatinIBA
03/2016 - 11/2006
3Activins (Activin)IBA
01/2016 - 03/2008
3Vascular Endothelial Growth Factor CIBA
01/2016 - 08/2012
3Mitogen-Activated Protein KinasesIBA
10/2014 - 05/2007
3major vault proteinIBA
11/2013 - 06/2005
3CardenolidesIBA
04/2013 - 09/2009
3Cardiac GlycosidesIBA
04/2013 - 09/2009
3narciclasineIBA
11/2010 - 02/2009
2IndazolesIBA
01/2022 - 01/2017
2SodiumIBA
01/2022 - 01/2017
2AcidsIBA
01/2022 - 04/2016
2Immune Checkpoint InhibitorsIBA
04/2021 - 02/2018
2Oxygen (Dioxygen)IBA
03/2021 - 11/2016

Therapy/Procedure

51Therapeutics
01/2022 - 12/2007
16Drug Therapy (Chemotherapy)
10/2021 - 10/2003
7Immunotherapy
04/2021 - 12/2016
4Precision Medicine
01/2020 - 10/2018
4Radiotherapy
09/2019 - 05/2011
4Transplantation
11/2018 - 04/2006
3Neoadjuvant Therapy
01/2019 - 10/2003